Evidence map›Paper›PMID 33133378›Full record

ReviewWorld journal of gastrointestinal oncology2020

Contemporary treatment approaches for metastatic colorectal cancer driven by

Ozkan Kanat, Hulya Ertas, Burcu Caner

Open access · diamondAbstract readReview
In one paragraph

Review in World journal of gastrointestinal oncology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 1 pooled it
1.8field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 1 synthesis or guideline pooled it, 15 citations in OpenAlex.

  1. Frontiers in oncology · 2022
    Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 3 institutions in 1 country.

Ozkan KanatDepartment of Medical Oncology, Acıbadem Bursa Hospital, Bursa 16059, Turkey. ozkanat@uludag.edu.tr.
Hulya ErtasDepartment of Medical Oncology, Bursa City Hospital, Bursa 16059, Turkey.
Burcu CanerDepartment of Medical Oncoloy, Balıkesir Ataturk City Hospital, Bursa 16059, Turkey.
Ankara Atatürk Eğitim ve Araştırma Hastanesi · TRBursa Technical University · TRBursa Uludağ Üni̇versi̇tesi̇ · TR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The treatment of metastatic colorectal cancer (mCRC) harboring

Indexed as

BRAF mutationMetastatic colorectal cancerTargeted therapiesV600 mutations

Identifiers

PMID33133378
PMCPMC7579731
OpenAlexW3092983377

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.